Columbia Biosciences Corporation, founded in 2007, develops and manufactures fluorescent proteins, antibody conjugates and novel protein purification ligands. In addition, our comprehensive custom services include antibody labeling, protein purification and discovery services such as functional cell based assays for pre-clinical drug development in oncology and immunology. Our expertise lies in the ability to integrate microalgae cultures with the isolation and purification of algal fluorophores, and with the conjugation of these and other fluorophores to antibodies. Columbia Biosciences’ fluorophores are integrated into a large number of life science products and diagnostic tools and are distributed globally.